ActRIIB-IN-2 is an ActRIIB inhibitor with an IC 50 of 1.1 nM. ActRIIB-IN-2 can be used for the research of cancer cachexia.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > TGF-beta/Smad | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > TGF-β Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.